Gene · 49
NIH grants1,192
NIH grants whose papers are about the gene, through NIH's grant-paper links.
521 to 540 of 1,192
Download this page as JSON| Grant | Title | ACR papers | Newest fiscal year |
|---|---|---|---|
| R01HL121230 | Childhood CV Risk and Adult CVD Outcomes: an International Long-term Follow-up | 1 | 2019 |
| R01HL138578 | Rapid Real-Time Cardiovascular MRI for Detecting Coronary Artery Disease | 1 | 2019 |
| R01MH077851 | 1/5 Bipolar-Schizophrenia Network for Intermediate Phenotypes 2 (B-SNIP 2) - Resu | 1 | 2019 |
| R01MH077945 | 3/5 Bipolar-Schizophrenia Network for Intermediate Phenotypes 2 (BSNIP-2) | 1 | 2019 |
| R01MH078113 | 4/5 Bipolar-Schizophrenia Network for Intermediate Phenotypes | 1 | 2019 |
| R21AI140406 | Neutralizing nanobodies as therapeutics for Dengue virus | 1 | 2019 |
| R21AI140491 | Identification and characterization of allosteric inhibitors of Zika protease by targeting the NS2B conformational change | 1 | 2019 |
| R21DK113420 | An Early Real-Time Electronic Health Record Risk Algorithm for the Prevention and Treatment of Acute Kidney Injury: A Randomized Trial of an Early Standardized, Personalized Nephrology Intervention | 1 | 2019 |
| R21HL143089 | Dietary Biomarkers and Cardioprotective Mechanisms of the DASH-Sodium Diet. | 1 | 2019 |
| R41AI142919 | Rapid high-resolution typing of Human Leukocyte Antigen genes by nanopore sequencing for transplantation | 1 | 2019 |
| R44DA044053 | Development and Evaluation of Video-Based Directly Observed Therapy for Office-Based Treatment of Opioid Use Disorders with Buprenorphine | 1 | 2019 |
| R56DK122380 | Biomanufacturing of Vascularized Kidney Tissues: A Foundational Step towards Building a Kidney | 1 | 2019 |
| T32DK007785 | Clinical Research Training in Kidney Disease | 1 | 2019 |
| T32GM007309 | Medical Scientist Training Program | 1 | 2019 |
| U01AI115940 | Inflammatory determinants of disease severity and treatment outcome in TB patients | 1 | 2019 |
| U01DK106962 | Leveraging Clinical Trials of Diabetic Kidney Disease to Advance Biomarkers | 1 | 2019 |
| U01EB028899 | Vascularized kidney organoids on chip for efficacy and toxicity testing of somatic genome editing | 1 | 2019 |
| U01EB029371 | Single Cell Profiling To Define Biomarkers Of Photoreceptor Dysfunction After Gene Editing Within PSC-Derived Organoids | 1 | 2019 |
| U19AI117950 | Engineering T cells to Provide Durable Control of HIV-1 Replication | 1 | 2019 |
| U54HD079123 | Intellectual and Developmental Disabilities Research Centers 2013 | 1 | 2019 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/49/grants?page=27